Follicular Lymphoma

Showing NaN - NaN of 32

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Follicular Lymphoma Trial in Houston (Bendamustine, Mitoxantrone, Rituximab)

Terminated
  • Follicular Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 1, 2020

Follicular Lymphoma Trial in Worldwide (IXAZOMIB)

Completed
  • Follicular Lymphoma
  • Boston, Massachusetts
  • +13 more
Oct 7, 2019

Follicular Lymphoma Trial in Worldwide (PF-05280586, MabThera®)

Completed
  • Follicular Lymphoma
  • PF-05280586
  • MabThera®
  • Anaheim, California
  • +422 more
Jun 18, 2019

CD20 Positive, Chronic Lymphocytic Leukemia, Follicular Lymphoma Trial in Houston (procedure, biological, drug)

Completed
  • CD20 Positive
  • +6 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
May 30, 2019

Acute Myelogenous Leukemia, Diffuse Large B-Cell Leukemia, Chronic Lymphocytic Leukemia Trial in United States (BMS-936564

Completed
  • Acute Myelogenous Leukemia
  • +3 more
  • BMS-936564 (Anti-CXCR4)
  • Birmingham, Alabama
  • +10 more
Mar 5, 2015

B-Cell Lymphoma, Follicular Lymphoma, Marginal Lymphoma Trial in United States (VELCADE and rituximab)

Completed
  • B-Cell Lymphoma
  • +2 more
  • VELCADE and rituximab
  • Los Angeles, California
  • +12 more
Feb 7, 2008